Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.12, read 2026-10-29
Ethical passes the values gate
Price228.90 USD
Fair value205.26
Ethical score70.0/100
Our investment reviews on this name
2026-10-28Read Accumulation237.27-3.5% to today Markdown gives way to Accumulation after a 5% rise in 2 weeks
2026-10-14Read Markdown225.67+1.4% to today Accumulation gives way to Markdown
2026-09-04Read Accumulation222.82+2.7% to today ✓Markup gives way to Accumulation after a 10% rise in 9 weeks
2026-07-02Read Markup201.94+13.4% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Matson, Inc. holds its Accumulation at $228.90. Consolidating, no directional conviction, held for 1 days.
As held on the ledger · 2026-10-28
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 1 days
Price at the screen
$228.90
Valuation
15.96 trailing · 14.12 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.30
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
15.69%
Below 33%
Interest-bearing debt is just 15.7% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
8.60%
Below 49%
Money owed to the company is 8.6% of assets, under the 49% limit.
Pass
Revenue purity
0.95%
Below 5%
Only 0.9% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Matson, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 16%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-29. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when MATX's ethical verdict changes
Today MATX passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-28 screen. The gold marker is the market price at the same screen. The price runs 10.3% above the base estimate.
Third-party analyst targets: 4 covering, consensus Strong Buy. The average target sits +17% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-28 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Shipping lanes look busy but the price does not
Every time a container ship pulls into Honolulu or Anchorage, Matson keeps the islands stocked with cars, food and building materials. The business clears a 13 percent profit margin and 16 percent return on equity, numbers that look solid on the surface. Yet revenue is already falling 3 percent and our fair value sits 17 percent below the current share price, so we pass.
The forward multiple of 14.4 times earnings may tempt buyers hunting for value in a cyclical trade. Peak shipping rates often produce exactly this pattern, low multiples that simply reflect earnings about to normalise lower. Analyst targets sit higher, but we see no margin of safety once the cycle turns.
Currency swings, fuel costs and sudden drops in freight demand remain live threats even though the ethical screen is clear. The combination of stretched valuation and cyclical exposure leaves no room for error. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
MATX trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-30Accumulation$228.90+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 72%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (3 analysts) rates it none, with a mean price target of $224. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Accumulation$228.90-3.5%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 72%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (3 analysts) rates it none, with a mean price target of $224. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 72%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (3 analysts) rates it none, with a mean price target of $224. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Markdown$237.27+5.1%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 5.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 25% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 72%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (3 analysts) rates it none, with a mean price target of $224. Insiders have been net sellers over the past quarter.
2026-10-14Markdown · changed$225.67+0.1%Entry 7
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 72%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (3 analysts) rates it none, with a mean price target of $224. Insiders have been net sellers over the past quarter.
2026-10-02Accumulation$225.50+1.2%Entry 6
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 72%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (3 analysts) rates it none, with a mean price target of $224. Insiders have been net sellers over the past quarter.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 10.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 72%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (3 analysts) rates it none, with a mean price target of $224. Insiders have been net sellers over the past quarter.
2026-08-05Markup$202.59+0.3%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 72%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (3 analysts) rates it none, with a mean price target of $224.
2026-07-18Markup$201.94+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 72%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (3 analysts) rates it none, with a mean price target of $224.
2026-07-03Markup$201.94+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
